SCHEMBL7226408

SCHEMBL7226408

CNC(=O)c1ccc2c(c1)C(=C(C)Nc1ccc(Cl)cc1)C(=O)N2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 1/20 0.47
KDR P35968 3/20 0.45
IP6K1 Q92551 1/20 0.44
IDO1 P14902 2/20 0.43
TDO2 P48775 2/20 0.43
TGM2 P21980 1/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NLRP1 Q9C000 1/20 0.40
PAK4 O96013 1/20 0.40
PDPK1 O15530 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7226405 1.00 LRRK2 (0.47) LRRK2KDRIP6K1IDO1TDO2
SCHEMBL7233945 0.88 TP53 (0.43) KDRKMT2AMAPTSMN1; SMN2PAK4
SCHEMBL7226273 0.88 LRRK2 (0.48) LRRK2KDRIP6K1IDO1TDO2
SCHEMBL7233951 0.88 TP53 (0.43) KDRKMT2AMAPTSMN1; SMN2PAK4
SCHEMBL12550474 0.87 AKT2 (0.40) LRRK2CA12CA1CA2CA9
SCHEMBL7982075 0.87 PAK4 (0.43) LRRK2KDRIP6K1CA12CA1
SCHEMBL6980872 0.87 PAK4 (0.43) LRRK2KDRIP6K1CA12CA1
SCHEMBL7224171 0.86 MAPT (0.47) LRRK2KDRIDO1TDO2TGM2
SCHEMBL7225808 0.86 LRRK2 (0.43) LRRK2KDRIDO1TDO2TGM2
SCHEMBL7225806 0.86 LRRK2 (0.43) LRRK2KDRIDO1TDO2TGM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6545035-B1 Having effect on various kinases and cycline/CDK complexes and on the proliferation of various tumour cells. BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-04-08 US disclosed
US-6319918-B1 FOR LYMPHOMA OR SOLID TUMORS TREATMENT BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-11-20 US disclosed